Jun 17, 2020
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
Jun 11, 2020
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress
Jun 03, 2020
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress
May 05, 2020
Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
May 01, 2020
Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
Apr 27, 2020
Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update
Feb 27, 2020
Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Feb 20, 2020
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results
Jan 13, 2020
Rigel Pharmaceuticals Provides Business Update
Jan 09, 2020
Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 17, 2019
Rigel Announces Chief Commercial Officer Transition
Nov 15, 2019
Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
Nov 13, 2019
Rigel to Present at Jefferies 2019 London Healthcare Conference
Nov 07, 2019
Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition
Oct 29, 2019
Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results
Oct 23, 2019
Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call
Oct 18, 2019
Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
Oct 16, 2019
Rigel to Host Investor and Analyst Call on October 23, 2019
Oct 02, 2019
Rigel Secures Credit Facility for Up to $60 Million
Sep 23, 2019
Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia